JPS61171413A - Hair tonic - Google Patents

Hair tonic

Info

Publication number
JPS61171413A
JPS61171413A JP661785A JP661785A JPS61171413A JP S61171413 A JPS61171413 A JP S61171413A JP 661785 A JP661785 A JP 661785A JP 661785 A JP661785 A JP 661785A JP S61171413 A JPS61171413 A JP S61171413A
Authority
JP
Japan
Prior art keywords
hair
blended
effect
hydroxy
decenoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP661785A
Other languages
Japanese (ja)
Other versions
JPH0559888B2 (en
Inventor
Katsuhiro Motoyoshi
本好 捷宏
Eihachi Saito
斉藤 英八
Hideo Kuroda
黒田 秀夫
Tetsuo Maeda
哲夫 前田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Orbis Holdings Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP661785A priority Critical patent/JPS61171413A/en
Publication of JPS61171413A publication Critical patent/JPS61171413A/en
Publication of JPH0559888B2 publication Critical patent/JPH0559888B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:A hair tonic which has improved hair growth promoting effect, is observed to have improved effect on male type baldness patient, shows improved effect on prevention of dandruff and fallen hair, etc., has improved effect and high safety, blended with a 10 hydroxy-DELTA<2>-decenoic acid. CONSTITUTION:A hair tonic is blended with 10 hydroxy-DELTA<2>-decenoic acid shown by the formula or one or more of its salts such as Na, K, 1/2Ca, NH4, ethanolamine, basic amino acid such as alginine, etc. directly or after it is dissolved in an alcohol and blended. The hair cosmetic contains 0.1-5.0wt% compound shown by the formula, and shows more improved effect when it is blended with a peripheral vasodilator of the skin such as CAPRONIUM chloride, vitamin E acetate, vitamin E nicotinate, etc. Types such as lotion, milky lotion, cream, oil gel, spray, etc., may be possible as the hair tonic, it is applied properly to the scalp once - twice daily, and preferably light massage or patting with brush, etc., is carried out.

Description

【発明の詳細な説明】 「発明の目的」 本発明は養毛効果、発毛促進効果に優れた安全性の高い
養毛群を提供せんとするものである。
DETAILED DESCRIPTION OF THE INVENTION OBJECT OF THE INVENTION The present invention aims to provide a highly safe hair nourishing group that has excellent hair nourishing and hair growth promoting effects.

「従来の技術」 従来、男性型の脱毛症や脂漏などの生理学的な徴候は、
男性ホルモンの過剰蓄積に起因する男性ホルモン刺激の
増大によると言われているが、最近、毛根、皮脂腺等の
器官におけるこの男性ホルモン活性の本体は、これら標
的器官においてテストステロンがテストステロン−5α
−レダクターゼという名の酵素(以下、レダクターゼと
略す。)によって還元された5α−ジヒドロテストステ
ロン(以下、5α−DHTと略す。)であることが周知
となってきている。即ち、電光や副腎で作られたテスト
ステロン(男性ホルモン)は血流にのって皮脂腺に行き
、皮脂腺細胞の中にあるレダクターゼによって、より強
力な男性ホルモンである5α−DHTK変換される。こ
の5α−DHTは細胞内の受容体と結合し、核に働いて
皮脂腺細胞の増殖を促す一方、それ自体はどのような過
程で皮脂腺細胞外に出て毛母細胞に働くのかは明らかで
はなかったが、5α−DHTが毛球部の毛母細胞の分裂
を抑制し、毛の成長を妨げるものとされている。
``Conventional technology'' Traditionally, physiological symptoms such as androgenetic alopecia and seborrhea are
It is said that this is due to increased stimulation of androgen due to excessive accumulation of androgen, but recently it has been revealed that the main body of this androgen activity in organs such as hair roots and sebaceous glands is that testosterone is activated by testosterone-5α in these target organs.
- It has become well known that 5α-dihydrotestosterone (hereinafter abbreviated as 5α-DHT) is reduced by an enzyme named reductase (hereinafter abbreviated as reductase). That is, testosterone (male hormone) produced by lightning and the adrenal glands travels through the bloodstream to the sebaceous glands, where it is converted to 5α-DHTK, a more powerful male hormone, by reductase in the sebaceous gland cells. While this 5α-DHT binds to intracellular receptors and acts on the nucleus to promote the proliferation of sebaceous gland cells, it is not clear by what process it leaves the sebaceous gland cells and acts on hair matrix cells. However, 5α-DHT is said to suppress the division of hair matrix cells in the hair bulb and impede hair growth.

従って、男性型の禿や脱毛などの徴候はレダクターゼの
活性を阻害すること、および5α−DHTと受容体タン
ノぐりとの結合を阻害することによシ低減または防止す
ることができると考えられ、この観点に基づいてこれま
でにいくつかの物質が見い出されている。しかし、これ
らの物質はレダクターゼ活性の阻害率は太き(ても、ホ
ルモン作用等の好ましくない副作用を有していたり、実
際に頭皮に塗布した場合に養毛効果が弱いなどの欠点を
有していた。又、古(から用いられているビタミンEニ
コチネートなどの皮膚末梢血管拡張剤も養毛効果の点で
は不十分なものであった。
Therefore, it is thought that symptoms such as male pattern baldness and hair loss can be reduced or prevented by inhibiting the activity of reductase and the binding of 5α-DHT to the receptor tannogiri. Several substances have been discovered so far based on this viewpoint. However, these substances have a high inhibition rate of reductase activity (although they have disadvantages such as having undesirable side effects such as hormonal effects, and having a weak hair growth effect when actually applied to the scalp). In addition, skin peripheral vasodilators such as vitamin E nicotinate, which have been used since ancient times, have been insufficient in terms of hair growth effect.

以上のように養毛料として現在使用されているものは、
上記の如(多かれ少なかれ欠点を有しており、新たな養
毛料の開発が望まれている。
As mentioned above, the products currently used as hair nourishing agents are:
As mentioned above, they have more or less drawbacks, and the development of new hair nourishing agents is desired.

[発明が解決しようとする問題点」 そこで、本発明者等はまず男性型の禿頭の禿げた部位を
Leitz社製MZ表面顕微鏡(X25)を用いて、詳
細に観察したところ、該部位には全く毛髪が無いという
のではなく、うぶ毛がまばらに発生している状態が観察
されたのである。
[Problems to be Solved by the Invention] Therefore, the inventors of the present invention first observed the bald area of a male's bald head in detail using a Leitz MZ surface microscope (X25), and found that the area had a Rather than having no hair at all, it was observed that downy hair was sparsely occurring.

即ち、男性型脱毛症は、長毛がへアーサイクルによって
生え変る毎に細く短くなりうぶ毛化した結果生じたもの
であシ、毛根部の毛母細胞および毛包の機能が何らかの
原因によって良えたことによるものと考えられる。さら
に本発明者等は、この男性型脱毛症患者の皮膚を生検し
、組織学的に観察した結果、表皮および真皮には特別な
異常は認められなかったが、毛根は萎縮し梶棒状になっ
ておシ、又、皮脂腺は異常に発達し肥大化していること
がわかった。すなわち、正常の長毛ではみられない皮脂
腺の異常発達が認められたのである。さらに多数の男性
型脱毛症患者について同様に調査し、検討した結果、脱
毛部位の頭皮は正常な頭皮に比較して、皮脂腺の発達が
顕著であり、皮脂腺細胞と毛母細胞の活動性は相反する
関係であることがわかった。
In other words, male pattern baldness is a result of long hair becoming thinner and shorter as it grows back through the hair cycle, becoming downy hair, and the function of the hair matrix cells and hair follicles at the root of the hair improves for some reason. This is thought to be due to this. Furthermore, the present inventors biopsied the skin of this patient with androgenetic alopecia and histologically observed it. Although no particular abnormality was observed in the epidermis or dermis, the hair roots atrophied and became rod-shaped. It was also discovered that the sebaceous glands were abnormally developed and enlarged. In other words, abnormal development of sebaceous glands, which is not seen in normal long hair, was observed. Furthermore, as a result of similar investigations and examinations of a large number of patients with androgenetic alopecia, it was found that the development of sebaceous glands in the scalp at the site of hair loss was more pronounced than in normal scalp, and the activities of sebaceous gland cells and hair matrix cells were contradictory. It turned out that the relationship was

つまり、皮脂腺の異常発達を抑制することによシ、頭皮
の脂漏および枇糠状態を改善し、さらにこれらに起因す
ると思われる脱毛症も効果的に予防できるのである。
In other words, by suppressing the abnormal development of sebaceous glands, it is possible to improve the seborrhea and bran condition of the scalp, and also to effectively prevent alopecia that is thought to be caused by these.

本発明者等はこのような作用を有する物質をハムスター
を用いた動物実験により幅広く探索したところ、10ヒ
ドロキシ−Δ2−デセン酸及びその塩に上記作用がある
ことを見出し、この知見に基づいて本発明を完成するに
至った。
The present inventors extensively searched for substances that have such an effect through animal experiments using hamsters, and found that 10-hydroxy-Δ2-decenoic acid and its salts had the above-mentioned effect.Based on this knowledge, the present inventors developed the present invention. The invention was completed.

すなわち本発明は下記の式(1) %式%(1) で表わされる10ヒドロキシ−d−デセン酸又はその塩
より選択される1種又は2種以上を配合することを特徴
とする養毛効果、発毛促進効果に優れた安全性の高い養
毛料に関するものである。
That is, the present invention provides a hair-nourishing effect characterized by incorporating one or more selected from 10-hydroxy-d-decenoic acid or its salt represented by the following formula (1) % formula % (1) , relates to a highly safe hair nourishing agent that has an excellent hair growth promoting effect.

「発明の構成」 本発明に用いられる10ヒドロキシ−Δ2−デセン酸及
びその塩は、市販のものをそのまま使用することができ
、新たに合成されたものでも、天然物より抽出されたも
のでも使用可能である。
"Structure of the Invention" The 10-hydroxy-Δ2-decenoic acid and its salts used in the present invention can be used as they are commercially available, or can be newly synthesized or extracted from natural products. It is possible.

上記の10ヒドロキシ−△2−デセン酸の塩としては、
デセン酸のカルボン酸部分がNa%に1%Ca。
As the above-mentioned salt of 10hydroxy-△2-decenoic acid,
The carboxylic acid part of decenoic acid is Na% and 1%Ca.

3AMgs NHa、)リエタノールアミン、塩基性ア
ミノ酸、例えばアルギニン、ヒスチジン、リシン、ヒド
ロキシリシン、オルニチン等、及びこれらを残基として
有するオリゴはプチド等によシ置換されたものでちゃ、
具体例としては10ヒトo キシ−Δ2− f セy 
ill カリウム塩[HOCH2<CH2)6−CH=
CHCOOK〕、10ヒドロキシ−Δ2−デセン酸アル
ギニン塩、などが挙げられる。もちろん、これらの塩は
そのまま配合しても、あるいは別々に添加して、養毛料
の製造工程中で反応させて塩にしても良い。尚、これら
のものは一般的に淡黄色〜白色の結晶性の粉末で臭いは
なく、水、エタノール、植物油などの養毛料基剤に可溶
である。又、上記10ヒドロキシ−Δ2−デセン酸及び
/又はその塩に加えて皮膚末梢血管拡張剤を含有せしめ
た養毛料はさらに好ましい効果を有するものである。こ
のような皮膚末梢血管拡張剤としては、例えば、塩化カ
プロニウム、ニコチン酸ベンジル、ビタミンEアセテー
ト、ビタミンEリル−ト、ビタミンEニコチネート等が
挙げられ、これらのうちの一種又は二種以上が使用され
る。
3AMgs NHa,) Reethanolamine, basic amino acids such as arginine, histidine, lysine, hydroxylysine, ornithine, etc., and oligos having these as residues must be substituted with peptide, etc.
A specific example is 10 human o xy-Δ2- f
ill Potassium salt [HOCH2<CH2)6-CH=
CHCOOK], 10-hydroxy-Δ2-decenoic acid arginine salt, and the like. Of course, these salts may be blended as they are, or may be added separately and reacted to form salts during the hair tonic manufacturing process. These substances are generally pale yellow to white crystalline powders that have no odor and are soluble in hair nourishment bases such as water, ethanol, and vegetable oil. Further, a hair tonic containing a skin peripheral vasodilator in addition to the above-mentioned 10-hydroxy-Δ2-decenoic acid and/or its salt has a more favorable effect. Examples of such skin peripheral vasodilators include capronium chloride, benzyl nicotinate, vitamin E acetate, vitamin E lyluate, vitamin E nicotinate, etc., and one or more of these may be used. Ru.

次に、本発明による養毛料としては、ローション、乳液
、クリーム、オイルゲル、水溶性ゲル、スプレー等種々
のタイプが可能であり、養毛効果を有する整髪料等も本
発明によシ提供される養毛料に含まれることは言うまで
もないことである。又、配合の方法は10ヒドロキシ−
Δ2−デセン酸及び/又はその塩を、そのまま又はアル
コール等に溶解して、従来の薬効成分等を配合するのと
同様の方法によシ養毛料に配合することができる。配合
量は凡そ0.01〜15.0重量%であり、好ましくは
0.1〜5.0重量−である。
Next, the hair nourishing agent according to the present invention can be of various types such as lotion, milky lotion, cream, oil gel, water-soluble gel, spray, etc., and the present invention also provides a hair styling agent having a hair nourishing effect. It goes without saying that it is included in hair nourishing products. Also, the method of compounding is 10 hydroxy-
Δ2-decenoic acid and/or its salt can be blended into the hair nourishing agent as it is or by dissolving it in alcohol or the like in the same manner as conventional medicinal ingredients are blended. The blending amount is approximately 0.01 to 15.0% by weight, preferably 0.1 to 5.0% by weight.

使用方法としては前記養毛料を1日1〜2回程度頭皮に
適量塗布し、軽くマツサージ又はブラシ等によるパッテ
ィングをすることが好ましい。
As for how to use it, it is preferable to apply an appropriate amount of the hair nourishing agent to the scalp once or twice a day, and lightly pat it with a pine surge or brush.

又、本発明に係わる養毛料には、10ヒドロキシ−Δ2
−デセン酸及び/又はその塩の他通常養毛料に用いられ
る添加剤たとえば、ヒノキチオール、カチオン界面活性
剤、パラベン等の殺菌剤、t−メントール、トウガラシ
チンキ等の清涼剤、スクワラン、高級アルコール等の油
分、その他界面活性剤、香料、酸化防止剤、サンスクリ
ーン剤、色素、エタノール、水等を配合することができ
る。
In addition, the hair nourishment according to the present invention contains 10 hydroxy-Δ2
- In addition to decenoic acid and/or its salts, additives commonly used in hair nourishing agents, such as hinokitiol, cationic surfactants, disinfectants such as parabens, cooling agents such as t-menthol and chili pepper tincture, squalane, higher alcohols, etc. Oil, other surfactants, fragrances, antioxidants, sunscreen agents, pigments, ethanol, water, etc. can be added.

〔実施例〕〔Example〕

次に本発明の実施例を示す。 Next, examples of the present invention will be shown.

実施例1 養毛料(a)(ローションタイプ)重量% B 精  製  水                
         155.6 (製法) 上記処方物Aを攪拌溶解し、これに上記処方物Bを添加
、混合して透明液状の養毛料を得た。
Example 1 Hair nourishing agent (a) (lotion type) Weight % B Purified water
155.6 (Production method) The above formulation A was stirred and dissolved, and the above formulation B was added thereto and mixed to obtain a transparent liquid hair nourishing agent.

実施例2 養毛料(b)(ローションタイプ)重量% (製法) 実施例1と同様の方法にて製品を得た。Example 2 Hair nourishing agent (b) (lotion type) weight% (Manufacturing method) A product was obtained in the same manner as in Example 1.

実施例3 養毛料(乳液タイプ) 重量% (製法) 上記処方物A及びBをそれぞれ80℃に加熱し混合攪拌
して均一に溶解せしめ、次に同温度で両成分を混合乳化
し、攪拌しながら常温まで冷却して製品を得た。
Example 3 Hair nourishing agent (emulsion type) Weight % (Production method) The above formulations A and B were heated to 80°C and mixed and stirred to uniformly dissolve them, and then both components were mixed and emulsified at the same temperature and stirred. A product was obtained by cooling to room temperature.

実施例4 養毛料(クリームタイプ) 重量% C香    料              0.2(
製法) 上記処方物Aを混合加熱して80℃とする。
Example 4 Hair nourishing agent (cream type) Weight% C fragrance 0.2 (
Manufacturing method) The above formulation A is mixed and heated to 80°C.

これに上記処方物Bを同様に混合加熱して80℃とした
ものを加え、ホモミキサーで均一に乳化し、上記Cを加
えて冷却し、製品とする。
To this is added Formulation B, which has been mixed and heated to 80° C. in the same manner, and homogeneously emulsified with a homomixer, and the above C is added and cooled to obtain a product.

「発明の効果」 次に、本発明において用いられる10ヒドロキシ−Δ2
−デセン酸及びその塩について、ノームスター耳介脂腺
を用いて脂腺肥大阻害テストを行ない結果を表−1に示
す。脂腺肥大の阻害率が大きいほど抗男性ホルモン作用
が強いことを表わす。
"Effect of the invention" Next, 10 hydroxy-Δ2 used in the present invention
- Decenoic acid and its salts were subjected to a sebaceous gland hypertrophy inhibition test using Normstar auricular sebaceous glands, and the results are shown in Table 1. The greater the inhibition rate of sebaceous gland hypertrophy, the stronger the anti-androgen effect.

試験方法は下記の通シである。The test method is as follows.

く検 体〉 プロピレングリコール−エタノール等容量混合液をベヒ
クルとし、10ヒドロキシ−Δ2−デセン駿及び10ヒ
ドロキシ−△2−デセン酸カリウム塩をそれぞれα1%
、α5%、10重量慢ベヒクル溶液としたものとブラン
クとしてベヒクルのみのもの計7品を検体とした。
Specimen> Using an equal volume mixture of propylene glycol and ethanol as the vehicle, α1% of each of 10-hydroxy-Δ2-decene and 10-hydroxy-Δ2-decenoic acid potassium salts was added.
A total of 7 samples were used, one containing α5%, 10 heavy vehicle solution and one using only vehicle as a blank.

脂腺肥大阻害テスト: 生後10週齢の雌性シリアンハムスターを1群6匹とし
、各検体群に群分けした後、実験筒1臼目及び第48目
に男性ホルモン剤であるテストステロンプロピオネート
t O’Ik (vr/v)流動ノ七ラフイン溶液を1
−背部皮下注射し、耳介脂腺を肥大させ、同時に実験筒
1臼目より1日1回7日間ハムスターの耳介に各検体を
塗布した。
Sebaceous gland hypertrophy inhibition test: 10-week-old female Syrian hamsters were divided into groups of 6, and after being divided into each sample group, the male hormone agent Testosterone Propionate T was applied to the 1st and 48th molars of the experimental tube. O'Ik (vr/v) liquid No. 7 rough in solution 1
- Injected subcutaneously in the back to enlarge the auricular sebaceous gland, and at the same time, each sample was applied to the auricle of the hamster once a day for 7 days from the first molar of the experimental tube.

災験第8日目に各群の動物の耳介中央部を剖検し、通常
の組織作成法により5μ厚の垂直切片を作成L、ヘマト
キシリン・エオシン染色をした後、ライヘルド投影器を
用いて脂腺断面積を測定した。脂腺肥大阻害率は下式に
より求めた。
On the 8th day of the disaster, the central part of the auricle of each group of animals was necropsied, and 5μ thick vertical sections were prepared using the standard tissue preparation method. Gland cross-sectional area was measured. The sebaceous gland hypertrophy inhibition rate was determined by the following formula.

尚、各群の脂腺断面積は6匹の平均値である。Note that the sebaceous gland cross-sectional area of each group is the average value of 6 animals.

脂腺肥大阻害率(慢)= 表−1 検   体        脂腺肥大阻害率@)10ヒ
ドロキシ−Δ2−デセン酸 0、11          17 0、51          34 1、 O%           4610ヒドロキシ
−Δ2−デセン酸カリウム頃0.1%        
     150.5チ            30
1、01            42以上の如(,1
0ヒドロキシ−Δ2−デセン酸及びその塩はテストステ
ロンプロピオネ−)Kよって誘発されたハムスター耳介
脂腺肥大の阻害効果、すなわち抗男性ホルモン作用を有
しており、その効果は、α1〜to重量−の範囲で濃度
依存性が確認されたのである。
Sebaceous gland hypertrophy inhibition rate (chronic) = Table 1 Sample Sebaceous gland hypertrophy inhibition rate @) 10 hydroxy-Δ2-decenoic acid 0, 11 17 0, 51 34 1, O% 4610 hydroxy-Δ2-decenoic acid potassium 0 .1%
150.5chi 30
1,01 42 or more (,1
0-hydroxy-Δ2-decenoic acid and its salts have an inhibitory effect on the hamster auricular sebaceous gland hypertrophy induced by testosterone propionate, that is, an anti-androgen effect, and the effect is Concentration dependence was confirmed in the - range.

次に、本発明において用いられる10ヒドロキシ−Δ2
−デセン酸について、マウスを用いて毛成長促進効果テ
ストを行ない結果を表−2に示す。
Next, 10 hydroxy-Δ2 used in the present invention
-Decenoic acid was tested for hair growth promoting effect using mice, and the results are shown in Table 2.

試験方法は下記の通シである。The test method is as follows.

毛成長促進効果テスト: く検 体〉 (1)10ヒドロキシ−Δ2−デセン酸0.1チC−/
V)95%エタノール溶液(本発明品) (ロ)95%エタノール液(ブランク)く試験方法〉 毛周期が休止期の状態にある生後8週齢の雄性03Hマ
ウス10匹を用い、実験第18目にマウス背部から尾部
にかけて抜毛し、背骨を中心線として左右にそれぞれ2
cm角の部位を作製した。次に、笑験第6日目よ)上記
検体をそれぞれの部位に1日1回α3d塗布し続け、第
14日月には各部位より毛を採取しその長さを測定し、
10本の平均値をその動物の当該部位の毛の長さとした
。表中の数値は10匹の平均値である。
Hair growth promotion effect test: Sample (1) 10hydroxy-Δ2-decenoic acid 0.1% C-/
V) 95% ethanol solution (product of the present invention) (B) 95% ethanol solution (blank) Test method> Experiment No. 18 was conducted using 10 8-week-old male 03H mice whose hair cycle is in the resting phase. Hair was removed from the back of the mouse to the tail, and two hairs were drawn on each side, centering around the spine.
A cm square part was prepared. Next, on the 6th day of the experiment, continue to apply α3d to each site once a day, and on the 14th day, collect hair from each site and measure its length.
The average value of the 10 hairs was taken as the length of the hair in that part of the animal. The values in the table are the average values of 10 animals.

表−2 検 体       毛の長さく關) 0)本発明品      Z4±0.5(ロ)ブランク
       5.8±0,4(イ)−(ロ)    
     t6±026±0促進率(%)= 以上の如く、本発明品はブランクに比して、約28慢マ
ウスの毛成長を促進するものであり、育毛効果が認めら
れたのである。これはおそらく毛根部における細胞賦活
作用によるものではないかと推察された。
Table-2 Specimen hair length) 0) Invention product Z4±0.5 (B) Blank 5.8±0.4 (A) - (B)
t6±026±0 promotion rate (%) = As described above, the product of the present invention promoted hair growth in approximately 28% arrogant mice compared to the blank, and a hair growth effect was observed. It was speculated that this was probably due to the cell activation effect in the hair root.

次に、本発明により提供される養毛群の養毛効果テスト
を行ない、結果を表−3に示す。
Next, a hair growth effect test was conducted on the hair growth group provided by the present invention, and the results are shown in Table 3.

″#1°″TffiO!D”r66・       怜
養毛効果テスト: 脂漏性脱毛症患者9名、枇糠性脱毛症患者3名、計12
名を被験者として、実施例1の養毛群を1日に2回(1
回に2.〇−投与)頭皮の脱毛部位に軽(マツサージを
しながら投与した。
″#1°″TffiO! D”r66・Rei hair growth effect test: 9 patients with seborrheic alopecia, 3 patients with pityriasis alopecia, 12 patients in total
The hair growth group of Example 1 was administered twice a day (1
2 times. 〇-Administration) Administered to the hair removal area of the scalp while performing a light massage.

このテストは医師の管理下において6か月実施され、3
か刃口に下記の3項目について医師の判定によシ評価し
た。
The test was conducted for 6 months under the supervision of a doctor and
The following three items were evaluated based on the judgment of the doctor.

・発毛促進効果十十:長毛が増生し九 十:うぶ毛が増生じた ±:変化なし m:脱毛部位が拡大した ・フケ防止効果 +:ニッケ減少した m:変化なし ・抜は毛防止効果+:抜は毛が減少したm:変化なし 表−3 表中の数値は例数であり、上段は脂漏性脱毛症患者、下
段は枇糠性脱毛症患者のものである。
・Hair growth promotion effect 10: Increased growth of long hair 90: Increased downy hair ±: No change m: Hair loss area expanded ・Dandruff prevention effect +: Reduced dandruff m: No change・Hair removal prevention Effect +: Reduced hair removal m: No change Table 3 The numbers in the table are the number of cases; the upper row is for patients with seborrheic alopecia, and the lower row is for patients with alopecia pityriasis.

以上の如く、本発明の養毛群は優れた発毛促進効果を有
しており、男性型脱毛症患者特に脂漏性脱毛症患者にお
いて顕著な効果が認められたのである。又、フケ防止効
果、抜は毛防止効果などにも優れた効果を発揮しており
、ホルモン作用等の好ましくない副作用も認められなか
った。以上の点を総合すると、本発明により提供される
養毛群は従来にない、養毛効果に優れた、安全性の高い
ものである。
As described above, the hair growth group of the present invention has an excellent hair growth promoting effect, and a remarkable effect was observed in patients with androgenetic alopecia, particularly in patients with seborrheic alopecia. It also exhibited excellent effects in preventing dandruff and hair removal, and no undesirable side effects such as hormonal effects were observed. Taking all the above points into consideration, the hair growth group provided by the present invention is unprecedented, has an excellent hair growth effect, and is highly safe.

Claims (1)

【特許請求の範囲】 1)下記の式(1) HOCH_2(CH_2)_6CH=CHCOOH(1
)で表わされる10ヒドロキシ−Δ^2−デセン酸又は
その塩より選択される1種又は2種以上を配合すること
を特徴とする養毛料。 2)10ヒドロキシ−Δ^2−デセン酸及び/又はその
塩を該養毛料中0.1〜5.0重量%含有する特許請求
の範囲第1)項記載の養毛料。 3)該養毛料中に塩化カプロニウム、ニコチン酸ベンジ
ル、ビタミンEアセテート、ビタミンEリノレート、ビ
タミンEニコチネート等の皮膚末梢血管拡張剤を含有す
る特許請求の範囲第1)項又は第2)項記載の養毛料。
[Claims] 1) The following formula (1) HOCH_2(CH_2)_6CH=CHCOOH(1
) 10hydroxy-Δ^2-decenoic acid or its salts, characterized in that it contains one or more selected from the following. 2) The hair nourishment according to claim 1), which contains 0.1 to 5.0% by weight of 10-hydroxy-Δ^2-decenoic acid and/or its salt. 3) Claim 1) or 2), wherein the hair nourishing agent contains a skin peripheral vasodilator such as capronium chloride, benzyl nicotinate, vitamin E acetate, vitamin E linoleate, vitamin E nicotinate, etc. Hair nourishment.
JP661785A 1985-01-17 1985-01-17 Hair tonic Granted JPS61171413A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP661785A JPS61171413A (en) 1985-01-17 1985-01-17 Hair tonic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP661785A JPS61171413A (en) 1985-01-17 1985-01-17 Hair tonic

Publications (2)

Publication Number Publication Date
JPS61171413A true JPS61171413A (en) 1986-08-02
JPH0559888B2 JPH0559888B2 (en) 1993-09-01

Family

ID=11643324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP661785A Granted JPS61171413A (en) 1985-01-17 1985-01-17 Hair tonic

Country Status (1)

Country Link
JP (1) JPS61171413A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510430A (en) * 1993-10-04 1997-10-21 アンドルックス ファーマスーティカルズ、インコーポレーテッド Controlled release potassium dosage form
JPH10147514A (en) * 1996-11-19 1998-06-02 Pola Chem Ind Inc Cosmetic
FR2840207A1 (en) * 2002-05-31 2003-12-05 B Prince Lab Scalp treatment uses a capillary lotion followed by brushing in a capillary conditioning cream and then washing with a shampoo, all with active ingredients to combat dandruff and hair loss,
WO2018034268A1 (en) * 2016-08-18 2018-02-22 株式会社山田養蜂場本社 Composition for amelioration of female pattern alopecia

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7426360B2 (en) 2021-08-31 2024-02-01 プライムプラネットエナジー&ソリューションズ株式会社 Positive electrode active material and non-aqueous electrolyte secondary battery containing the same
JP7434230B2 (en) 2021-08-31 2024-02-20 プライムプラネットエナジー&ソリューションズ株式会社 Positive electrode active material and non-aqueous electrolyte secondary battery containing the same
JP2023034699A (en) 2021-08-31 2023-03-13 プライムプラネットエナジー&ソリューションズ株式会社 Positive electrode and nonaqueous electrolyte secondary battery using the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510430A (en) * 1993-10-04 1997-10-21 アンドルックス ファーマスーティカルズ、インコーポレーテッド Controlled release potassium dosage form
JPH10147514A (en) * 1996-11-19 1998-06-02 Pola Chem Ind Inc Cosmetic
FR2840207A1 (en) * 2002-05-31 2003-12-05 B Prince Lab Scalp treatment uses a capillary lotion followed by brushing in a capillary conditioning cream and then washing with a shampoo, all with active ingredients to combat dandruff and hair loss,
WO2018034268A1 (en) * 2016-08-18 2018-02-22 株式会社山田養蜂場本社 Composition for amelioration of female pattern alopecia
CN109640945A (en) * 2016-08-18 2019-04-16 株式会社山田养蜂场本社 Composition is used in the improvement of gynecoid type epilation disease
JPWO2018034268A1 (en) * 2016-08-18 2019-04-25 株式会社山田養蜂場本社 Composition for improving female pattern baldness
CN109640945B (en) * 2016-08-18 2022-04-29 株式会社山田养蜂场本社 Composition for improving female alopecia

Also Published As

Publication number Publication date
JPH0559888B2 (en) 1993-09-01

Similar Documents

Publication Publication Date Title
JP3597210B2 (en) Hair restoration
JPS61171413A (en) Hair tonic
JPS6293215A (en) Hair tonic
JP4162823B2 (en) Hair cosmetics
JPS62175417A (en) Hair tonic cosmetic
JP2001288046A (en) Composition for scalp and hair
JPH07277920A (en) Cosmetic containing steam-distilled water and/or extract of lemongrass
JP2546813B2 (en) Hair nourishing cosmetics
JP3205601B2 (en) Hair restorer
JPS60199810A (en) Hair tonic cosmetic
JPH04305517A (en) Hair care cosmetics
JP2774071B2 (en) Hair restoration cosmetics
JP2000026269A (en) Cosmetic
JPH0820521A (en) Keratinizing enzyme activity promoter and cosmetic containing the same
JP3193544B2 (en) Hair restoration cosmetics
JP2000016920A (en) Hair tonic cosmetic
JPS62103005A (en) Hair tonic cosmetic
JPS6118711A (en) Hair tonic
JP2004026812A (en) Hair tonic
JP3717676B2 (en) Hair nourishing
JPH0788294B2 (en) Cosmetics
JP2955055B2 (en) Hair restoration cosmetics
JPS6168408A (en) Hair tonic
JP2000044436A (en) Composition for scalp and hair treatment
JPH1077216A (en) Hair-restoring cosmetic material

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term